Covered recipient · General Payments record
ROBYN T DOMSIC
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$25,800.85
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $18,135.00 | 3 |
| Travel and Lodging | $1,164.36 | 3 |
| Food and Beverage | $184.33 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $17,277.00 | 3 |
| AstraZeneca UK Limited | $2,206.69 | 5 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,255.00 | 01/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104568312 | CMS |
| AstraZeneca Pharmaceuticals LP | $13,950.00 | 07/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104436361 | CMS |
| AstraZeneca Pharmaceuticals LP | $72.00 | 08/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104614842 | CMS |
| AstraZeneca UK Limited | $228.00 | 06/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1093891286 | CMS |
| AstraZeneca UK Limited | $49.35 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093984701 | CMS |
| AstraZeneca UK Limited | $864.36 | 06/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1094045295 | CMS |
| AstraZeneca UK Limited | $134.98 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094048377 | CMS |
| AstraZeneca UK Limited | $930.00 | 12/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094011284 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.